Combination bnAbs Sustained Viral Suppression in Children After ART Interruption

Originally published by our sister publication Infectious Disease Special EditionBy Ethan CoveyCombination broadly neutralizing antibodies (bnAbs) maintained viral suppression for 24 weeks in the first children in Botswana with HIV to receive dual- or triple-bnAb treatment after scheduled antiretroviral (ART) therapy interruption, according to preliminary findings (abstract 152) presented at CROI 2026, in Denver.figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em